Vital KSK Holdings, Inc. (TYO:3151)

Market Cap	61.50B
Revenue (ttm)	602.28B
Net Income (ttm)	6.96B
Shares Out	48.27M
EPS (ttm)	143.12
PE Ratio	8.90
Forward PE	n/a
Dividend	68.00 (5.30%)
Ex-Dividend Date	Sep 29, 2025

Volume	197,900
Average Volume	135,775
Open	1,274.00
Previous Close	1,282.00
Day's Range	1,268.00 - 1,279.00
52-Week Range	1,093.00 - 1,396.00
Beta	0.11
RSI	60.33
Earnings Date	Aug 6, 2025

About Vital KSK Holdings

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. It operates through Pharmaceutical Wholesale Business; Pharmacy Business; Veterinary Drug Wholesale Business; and Other Businesses. The company is involved in the nursing care; agrochemical wholesale; and sale of pharmaceuticals, poisonous or deleterious substances, narcotics, quasi-drugs, vaccines, paints, pigments, dyes, medical equipment, sanitary materials, hygiene goods, nursing care products, and beverages. It also engages in the medical...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Employees: 3,756
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3151

Financial Performance

In 2024, Vital KSK Holdings's revenue was 600.37 billion, an increase of 2.19% compared to the previous year's 587.48 billion. Earnings were 7.31 billion, an increase of 25.07%.